1.Combined Mucinous Tumor and Carcinoid of Appendix Associated with Mucinous Tumor of Ovary and Pseudomyxoma Peritonei: A case report .
Korean Journal of Pathology 1999;33(11):1094-1096
We report a case of mucinous cystadenoma of uncertain malignant potential and carcinoid of appendix associated with bilateral mucinous cystadenoma of ovary and pseudomyxoma peritonei. The patient was a 46-year-old female. She suffered from dyspnea and lower abdominal palpable masses for several months. Ultrasonogram showed multilocular huge ovarian cysts. Appendectomy, transabdominal hysterectomy, bilateral salphingo-oophorectomy and biopsy of omentum were performed. The bilateral ovaries measured 16 11 cm and 7X5 cm in size, respectively. The both ovaries showed multilocular cysts filled with thick mucus material. The ovarian cysts were covered by a single layer of columnar epithelium with focal proliferation. Mucus materials dissected through the ovarian stroma (pseudomyxoma ovarii). The tip of appendix was dilated and covered by mucus material. The cut surface showed a cyst and a yellowish solid mass proximal to the cyst. Microscopically, the appendiceal cyst was lined by stratified columnar epithelium with moderate cytologic atypia. Mucus material dissected through the wall. In the proximal portion of the appendix, a classic carcinoid with focal tubular form was present in submucosa and muscle layer. The omentum was covered by thick mucus material. Microscopically, the omentum showed mucinous epithelium and mucus material (pseudomyxoma peritonei).
Appendectomy
;
Appendix*
;
Biopsy
;
Carcinoid Tumor*
;
Cystadenoma, Mucinous
;
Dyspnea
;
Epithelium
;
Female
;
Humans
;
Hysterectomy
;
Middle Aged
;
Mucins*
;
Mucus
;
Omentum
;
Ovarian Cysts
;
Ovary*
;
Pseudomyxoma Peritonei*
;
Ultrasonography
2.Combined Mucinous Tumor and Carcinoid of Appendix Associated with Mucinous Tumor of Ovary and Pseudomyxoma Peritonei: A case report .
Korean Journal of Pathology 1999;33(11):1094-1096
We report a case of mucinous cystadenoma of uncertain malignant potential and carcinoid of appendix associated with bilateral mucinous cystadenoma of ovary and pseudomyxoma peritonei. The patient was a 46-year-old female. She suffered from dyspnea and lower abdominal palpable masses for several months. Ultrasonogram showed multilocular huge ovarian cysts. Appendectomy, transabdominal hysterectomy, bilateral salphingo-oophorectomy and biopsy of omentum were performed. The bilateral ovaries measured 16 11 cm and 7X5 cm in size, respectively. The both ovaries showed multilocular cysts filled with thick mucus material. The ovarian cysts were covered by a single layer of columnar epithelium with focal proliferation. Mucus materials dissected through the ovarian stroma (pseudomyxoma ovarii). The tip of appendix was dilated and covered by mucus material. The cut surface showed a cyst and a yellowish solid mass proximal to the cyst. Microscopically, the appendiceal cyst was lined by stratified columnar epithelium with moderate cytologic atypia. Mucus material dissected through the wall. In the proximal portion of the appendix, a classic carcinoid with focal tubular form was present in submucosa and muscle layer. The omentum was covered by thick mucus material. Microscopically, the omentum showed mucinous epithelium and mucus material (pseudomyxoma peritonei).
Appendectomy
;
Appendix*
;
Biopsy
;
Carcinoid Tumor*
;
Cystadenoma, Mucinous
;
Dyspnea
;
Epithelium
;
Female
;
Humans
;
Hysterectomy
;
Middle Aged
;
Mucins*
;
Mucus
;
Omentum
;
Ovarian Cysts
;
Ovary*
;
Pseudomyxoma Peritonei*
;
Ultrasonography
3.The Effect of Hormonal Replacement Therapy on Breast.
Mi Hye KIM ; Ki Keun OH ; Mi Gyoung JEONG
Journal of the Korean Radiological Society 1995;33(3):457-463
PURPOSE: To evaluate mammographic and sonographic breast parenchymal changes and the risk of breast cancer in women on hormonal replacement therapy (HRT). MATERIAL AND METHODS: The study group consisted of 50 patients examined with serial mammograms and/or ultrasonograms during HRT. The control group consisted of 50 patients examined with serial mammogram for a routine health check. Mammographic parenchymal changes in both the study and control groups and so- nographic findings of 27/50 patients in study group were evaluated. RESULTS: Follow-up mammogram of the control group showed no interval change or slight evolution of parenchyma with increasing age, but the study group showed increasing parenchymal densities. Most frequently encountered finding on SOhogram in 11 women treated by estrogen alone, was ductal dilatation (7cases ;64%), whereas in 16 women treated by estrogen and progesteron it was ductal epithelial hyperplasia (8 cases; 50%). Overall, four breast cancers developed;one infiltrating ductal carcinoma and three ductal carcinoma in situ. CONCLUSION: HRT causes the changes of breast parenchyma on mammogram and sonogram of postmenopausal women, and increases the risk of developing breast cancer. Therefore, careful and regular examination should be followed in those on postmenopausal HRT.
Breast Neoplasms
;
Breast*
;
Carcinoma, Ductal
;
Carcinoma, Intraductal, Noninfiltrating
;
Dilatation
;
Estrogens
;
Female
;
Follow-Up Studies
;
Humans
;
Hyperplasia
;
Ultrasonography
4.Availability of creamatocrit in breast milk jaundice.
Mi Jung KIM ; Hye Kyung HAN ; Mi Na LEE
Korean Journal of Perinatology 1993;4(1):29-36
No abstract available.
Breast*
;
Jaundice*
;
Milk, Human*
5.Study for Metabolism of Resistant Production in Anticancer drug Resistant Stomach Cancer Cell SNU-1.
Jung Hye KIM ; Mi Wha KANG ; Jae Ryong KIM
Yeungnam University Journal of Medicine 1989;6(2):195-205
Development of drug resistance in tumors during treatment is a major factor limiting the clinical use of anticancer agents. When tumor cells acquire resistance to anticancer drug, they show cross-resistance to other antitumor agents. In the present study, SNU-1 cell was induced adriamycin 10-7 drug resistance, SNU-1/ADR, in vitro culture system. We got the doubling time and number for viability test during 96 hours by MTT assay. To investigate the cross resistance of various anticancer drugs in human stomach cancer cell SNU-1 and SNU-1/ADR, We compared IC50 (drug concentration of 50% reduction) and the relative resistance (RR). SNU-1/ADR was expressed multidrug resistant with vinblastine (RR;>31.62), vincristine (RR;29.50), dactinomycin (RR;21.37), epirubicin (RR;17.78), daunorubicin (RR;14.12), adriamycin (RR;7.76), and etoposide (RR;4.46), and other drugs, 5-fluorouracil, cisplatin, cyclophosphamide, methotrexate, and calarubicin, have not cross resistant with adriamycin. There was double minute chromosome in SNU-1/ADR by karyotyping although this change was not seen in SUN-1.
Antineoplastic Agents
;
Cisplatin
;
Cyclophosphamide
;
Dactinomycin
;
Daunorubicin
;
Doxorubicin
;
Drug Resistance
;
Epirubicin
;
Etoposide
;
Fluorouracil
;
Humans
;
In Vitro Techniques
;
Inhibitory Concentration 50
;
Karyotyping
;
Metabolism*
;
Methotrexate
;
Stomach Neoplasms*
;
Stomach*
;
Vinblastine
;
Vincristine
6.Radiographic findings of mycoplasma pneumonia in adult.
Sang Jin KIM ; Mi Hye KIM ; Kyu Ok CHOE
Journal of the Korean Radiological Society 1991;27(3):373-376
No abstract available.
Adult*
;
Humans
;
Mycoplasma*
;
Pneumonia, Mycoplasma*
7.Evaluation of Pulmonary Venous, Mitral and Aortic Flow Pattern by Doppler Echocardiography in Neonates.
Hye Soon KIM ; Young Mi HONG ; Gyoung Hee KIM
Journal of the Korean Pediatric Society 1994;37(5):596-605
Pulmonary vein velocities have recently been estimated in conjunction with mitral flow velocities to increase our understanding o ventricular filling. The advent of transesophageal echocardiography with pulsed Doppler imaging capability has provided a method by which both the mitral valve and pulmonary vein velocities can be easily recorded because of the posterior approach providing unimpeded interrogation of cardiac structures. The purpose of this present study was to evaluate the normal pulmonary venous, mitral and aortic flow pattern by transthoracic echocardiography in neonate according to the postnatal age. The results were as follows. 1) With regard to the aortic flow, the early systolic was of pulmonary flow peaked after the onset of aortic flow and the late systolic wave occured consistently before aortic valve closure. 2) The peak velocities of early systolic, late systolic, late systolic, diastolic and atrial systolic in the pulmonary venous flow were 36.4 (13.2cm/sec, 45.3 (15.3cm/sec, 48.5 (14.1cm/sec and 16.6( 5.7cm/sec at 1 day old. the difference according to the postnatal age was not significant. 3) The ratio of peak systolic to peak distolic velocity of pulmonary venous flow was 1.0( 0.3 at 1 day o1, 1.1( 0.4 at 1 week old and 1.2 (0.3 at 1 month old. The difference between old and 1 month old was statistically significant(p<0.05). 4) The peak early diastolic velocity of mitral flow was 51.3 (15.2cm/sec at 1 day old, 54.7( 13.7cm/sec at 1 week old and 80.7 (16.6cm/sec at 1 month old. The difference between 1 week old and 1month old was statistically significant(p<0.01). 5) The peak late diastolic velocity of mitral flow was 48.3 (14.6cm/sec at 1 day old, 50.1( 9.9cm/sec at 1 week old and 71.8 (16.6cm/sec at 1 month old. The difference between 1 week old and 1 month old was statistically significant(p<0.01). 6) The ratio of peak mitral early diastolic to peak late diastolic velocity was 1.1( 0.2 at 1 day old, 1.1( 0.3 at 1 week old and 1.2( 0.7at 1 month old. The difference between 1 week old and 1 month old was statistically significant(p<0.01). 7) The peak aortic valve flow velocity was 62.1 (14.2cm/sec at 1 day old, 67.8 13.4cm/sec at 1 week old and 76.6 14.1cm/sec at 1 month old. The difference between old and 1 month old was statistically significant(p<0.05). In conclusion, improvement of left ventricular diastolic function was noted at 1 month old by echocardiography. These normal data will be useful in comprisons with the data, which obtained in newborn with various congenital heart disease that affects flow dynamics.
Aortic Valve
;
Echocardiography
;
Echocardiography, Doppler*
;
Echocardiography, Transesophageal
;
Heart Defects, Congenital
;
Humans
;
Infant, Newborn*
;
Mitral Valve
;
Pulmonary Veins
8.A case of ruptured interstitial pregnancy with 19 weeks gestation.
Do Yung CHOI ; Mi Kyung KIM ; Hyang Mi LEE ; Hye Mi LEE ; Sam Soo HO
Korean Journal of Obstetrics and Gynecology 1993;36(1):106-115
No abstract available.
Pregnancy*
9.The association between unexplained elevations of midtrimester human chorionic gonadotropin and pregnancy - induced hypertension.
Mi Young CHOI ; Mi Ran KIM ; Eun Kew KIM ; Hyun Jin KIM ; Mi Hee KIM ; Hye Ran HWANG
Korean Journal of Obstetrics and Gynecology 2000;43(9):1656-1661
No abstract available.
Chorionic Gonadotropin*
;
Female
;
Humans
;
Humans*
;
Hypertension*
;
Pregnancy
;
Pregnancy Trimester, Second*
;
Pregnancy*
10.Clinical Course and Predictable Factors for Remission of Hashimoto' Thyroiditis in Children and Adolescents.
Keun Hye LEE ; Mi Jung KIM ; Heon Seok HAN
Journal of Korean Society of Pediatric Endocrinology 2004;9(1):34-41
PURPOSE:The natural course of Hashimoto' thyroiditis (HT) is so dynamic that the disease progresses to overt hypothyroid or spontaneous recovery. The authors reviewed the clinical course of this disease and analysed the possible predicting factors regarding remission. METHODS:Thirty nine patients with HT (38 girls and 1 boy) were studied retrospectively. Of these patients, 30 were followed for more than 2 years. The possible remission factors were analyzed at initial diagnosis and during follow-up period. RESULTS:The mean age at the diagnosis was 11.8+/-.1 years. Initial thyroid function was euthyroid in 38.5%, compensated hypothyroid in 35.9%, overt hypothyroid in 23.1%, and hyperthyroid in 2.6% of patients. Antithyroglobulin antibody (ATA) was positive in 94.7%, and antimicrosomal antibody (AMA) was positive in 74.4%. The overall remission rate was 53.3% during the follow-up period (51+/-7 months). Initial goiter size, thyroid function status, and autoantibody titer had no relation to the remission rate statistically. Follow-up autoantibody titers in remission group were marginally lower than those in nonremission group (P<0.1), and follow-up AMA titer was significantly higher than initial titers in nonremission group (P<0.05). CONCLUSION: We could not find any predictable remission factors from the initial clinical and autoantibody status. But, during follow-up period, patients with lower autoantibody titers showed slight higher remission, and those with increasing AMA titer showed less remission. Above results suggest that we should monitor antithyroid antibody titer as well as thyroid function regularly.
Adolescent*
;
Child*
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Goiter
;
Humans
;
Retrospective Studies
;
Thyroid Gland*
;
Thyroiditis*